secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2021-12-22T23:59:59+00:00
Accession:  0001493152-21-032259
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics enters revised employment agreement with CFO, base salary $200K
------------------------------------------------------------------------------

- Employment agreement effective Jan 3, 2022; at-will; base salary $200,000.
- Annual target bonus of 25% of base salary, subject to board-set objectives.
- Stock option grant of 25,000 shares with 2-year maturity at market price.
- CFO Deina H. Walsh has served since Nov 2014; new agreement updates terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315221032259/0001493152-21-032259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315221032259/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-032259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer